Héctor Barajas-Martínez
About
In The Last Decade
Héctor Barajas-Martínez
96 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 102
- Cardiology and Cardiovascular Medicine 1.8k
- Molecular Biology 1.5k
- Cellular and Molecular Neuroscience 346
- Surgery 94
- Pathology and Forensic Medicine 60
Countries citing papers authored by Héctor Barajas-Martínez
This map shows the geographic impact of Héctor Barajas-Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héctor Barajas-Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héctor Barajas-Martínez more than expected).
Fields of papers citing papers by Héctor Barajas-Martínez
This network shows the impact of papers produced by Héctor Barajas-Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héctor Barajas-Martínez. The network helps show where Héctor Barajas-Martínez may publish in the future.
Co-authorship network of co-authors of Héctor Barajas-Martínez
This figure shows the co-authorship network connecting the top 25 collaborators of Héctor Barajas-Martínez. A scholar is included among the top collaborators of Héctor Barajas-Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Héctor Barajas-Martínez. Héctor Barajas-Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 19 | |
| 3 | 12 | |
| 4 | 6 | |
| 5 | 19 | |
| 6 | Abstract 12335: Acacetin, a Potent Transient Outward Current Blocker, May Serve as a Novel Therapeutic for KCND3-encoded Kv4.3 Gain-of-function-associated Brugada Syndrome | 1 |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 18 | |
| 10 | 14 | |
| 11 | 38 | |
| 12 | 27 | |
| 13 | Abstract 15739: Effects of Ranolazine on Long QT3 Syndrome are Mutation Dependent | 1 |
| 14 | 140 | |
| 15 | Abstract 15855: A Novel Mutation (D538E) in CACNB2b Associated with Infant Brugada Syndrome | 1 |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | Abstract 1471: Novel Mutation in the KCNQ1 Associated with Brugada Syndrome | 2 |
| 20 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.